3E6-28957-86556
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-22
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Dose 2 — Pfizer-BioNTech
-
2021-03-16
Registered in v-safe
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Abortion spontaneous — Feeling: Poor · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to workFree text: MiscarriageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-18
- 2021-09-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-22 | Pfizer-BioNTech | |
| 2 | 2021-03-15 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-16 | priority 2/3 |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Abortion spontaneous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release